Jul 31, 2026
Researchers have identified an immune response that may explain why statins cause muscle pain, weakness, and exercise intolerance in some patients. The finding could eventually lead to treatments that prevent these side effects.
Novo Nordisk's experimental inflammation-targeting drug failed to reduce the risk of heart attacks and strokes in a closely watched large clinical trial, a setback for the drugmaker's growth prospects beyond obesity and diabetes.
Multiple news outlets published practical guides on bicycle commuting, featuring advice on safety, preparation, and arriving presentable at work. The articles highlight Chicago pub owner Michael Roper, 72, as an example of successful bike commuting.
Mayo Clinic study finds metabolic and bariatric surgery provides significantly greater long-term cardiovascular risk reduction compared to GLP-1 medications in people with obesity, despite both treatments improving heart health.
Two studies report that targeted, noninvasive radiation therapy (proton beam therapy) reduced episodes of life-threatening cardiac arrhythmias by nearly 80% in critically ill patients, representing the first large-scale and first-in-human evidence for this approach.
A study published in The Lancet found over 2.5 million sudden deaths—natural unexpected deaths occurring within one hour of symptom onset—occurred across 26 European countries from 2010 to 2020, representing a 30% increase with a disproportionately sharper rise among women.
A global clinical trial found that GMRx2, a single pill combining three low-dose blood pressure medications, significantly reduced the risk of recurrent stroke in patients with intracerebral hemorrhage and high blood pressure by approximately 40%.